Gao R, Brigstock D R
Center for Cell and Vascular Biology, Children's Research Institute, Columbus, OH 43205, USA.
Gut. 2006 Jun;55(6):856-62. doi: 10.1136/gut.2005.079178. Epub 2005 Dec 16.
Connective tissue growth factor (CCN2) is upregulated in pancreatic fibrosis and desmoplastic pancreatic tumours. CCN2 interacts with integrin alpha5beta1 on pancreatic stellate cells (PSC) in which it stimulates fibrogenesis, adhesion, migration, and proliferation.
To determine the structural domain(s) in CCN2 that interact with integrin alpha5beta1 to regulation PSC functions.
Primary activated rat PSC were tested for their adherence to isoforms of CCN2 comprising modules 1-4 (CCN2(1-4)), modules 3-4 (CCN2(3-4)), module 3 alone (CCN2(3)), or module 4 alone (CCN2(4)). Adhesion studies were performed in the presence of EDTA, divalent cations, anti-integrin alpha5beta1 antibodies, CCN2 synthetic peptides, or heparin, or after pretreatment of the cells with heparinase, chondroitinase, or sodium chlorate. CCN2 integrin alpha5beta1 binding was analysed in cell free systems. The ability of CCN2(1-4), CCN2(3-4), or CCN2(4) to stimulate PSC migration was evaluated in the presence of anti-integrin alpha5beta1 or heparin.
PSC adhesion was stimulated by CCN2(1-4), CCN2(3-4), or CCN2(4) and supported by Mg2+ but not Ca2+. CCN2(4) supported PSC adhesion or migration were blocked by anti-integrin alpha5beta1 antibodies or by treatment of cells with heparinase or sodium chlorate. A direct interaction between CCN2(4) and integrin alpha5beta1 was demonstrated in cell free assays. The sequence GVCTDGR in module 4 mediated the binding between CCN2(4) and integrin alpha5beta1 as well as CCN2(4) mediated PSC adhesion and migration.
A GVCTDGR sequence in module 4 of CCN2 is a novel integrin alpha5beta1 binding site that is essential for CCN2 stimulated functions in PSC and which represents a new therapeutic target in PSC mediated fibrogenesis.
结缔组织生长因子(CCN2)在胰腺纤维化和促结缔组织增生性胰腺肿瘤中上调。CCN2与胰腺星状细胞(PSC)上的整合素α5β1相互作用,刺激其纤维化、黏附、迁移和增殖。
确定CCN2中与整合素α5β1相互作用以调节PSC功能的结构域。
检测原代激活的大鼠PSC对包含模块1 - 4(CCN2(1 - 4))、模块3 - 4(CCN2(3 - 4))、单独的模块3(CCN2(3))或单独的模块4(CCN2(4))的CCN2异构体的黏附情况。在存在乙二胺四乙酸(EDTA)、二价阳离子、抗整合素α5β1抗体、CCN2合成肽或肝素的情况下,或在用肝素酶、软骨素酶或氯酸钠预处理细胞后进行黏附研究。在无细胞系统中分析CCN2与整合素α5β1的结合。在存在抗整合素α5β1或肝素的情况下,评估CCN2(1 - 4)、CCN2(3 - 4)或CCN2(4)刺激PSC迁移的能力。
CCN2(1 - 4)、CCN2(3 - 4)或CCN2(4)刺激PSC黏附,且这种黏附由Mg2 +而非Ca2 +支持。抗整合素α5β1抗体或用肝素酶或氯酸钠处理细胞可阻断CCN2(4)支持的PSC黏附或迁移。在无细胞试验中证实了CCN2(4)与整合素α5β1之间的直接相互作用。模块4中的序列GVCTDGR介导了CCN2(4)与整合素α5β1之间的结合,以及CCN2(4)介导的PSC黏附和迁移。
CCN2模块4中的GVCTDGR序列是一个新的整合素α5β1结合位点,对CCN2刺激PSC的功能至关重要,并且是PSC介导的纤维化形成中的一个新治疗靶点。